Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert M Swift

Showing results (1-10 of 90) with videos related to

Pageof 9
Sort By:
The American Journal on Addictions|February 20, 2004
Current pharmacotherapies of alcoholism: a U.S. perspectiveRaymond F Anton, Robert M Swift
Harvard Review of Psychiatry|March 10, 2015
Pharmacotherapy for alcohol use disorder: current and emerging therapiesRobert M Swift, Elizabeth R Aston
Human Psychopharmacology|June 25, 2009
A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcoholGeorge A Kenna, Lorenzo Leggio, Robert M Swift
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 22, 2007
New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medicationsLorenzo Leggio, George A Kenna, Robert M Swift
Psychopharmacology|February 21, 2018
Noradrenergic targets for the treatment of alcohol use disorderCarolina L Haass-Koffler, Robert M Swift, Lorenzo Leggio
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2004
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1George A Kenna, John E McGeary, Robert M Swift
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 8, 2004
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2George A Kenna, John E McGeary, Robert M Swift
Current Pharmaceutical Design|April 29, 2011
Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a reviewSteven Edwards, George A Kenna, Robert M Swift, et al.
Neuropsychology Review|July 10, 2012
The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humansGeorge A Kenna, Robert M Swift, Thomas Hillemacher, et al.
Substance Use & Misuse|December 23, 2009
HIV testing in hazardous drinking: a survey analysisMiriam Fenton, Lorenzo Leggio, George A Kenna, et al.
Pageof 9

Showing results (1-10 of 90) with videos related to

Sort By:
Pageof 9
The American Journal on Addictions|February 20, 2004
Current pharmacotherapies of alcoholism: a U.S. perspectiveRaymond F Anton, Robert M Swift
Harvard Review of Psychiatry|March 10, 2015
Pharmacotherapy for alcohol use disorder: current and emerging therapiesRobert M Swift, Elizabeth R Aston
Human Psychopharmacology|June 25, 2009
A safety and tolerability laboratory study of the combination of aripiprazole and topiramate in volunteers who drink alcoholGeorge A Kenna, Lorenzo Leggio, Robert M Swift
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 22, 2007
New developments for the pharmacological treatment of alcohol withdrawal syndrome. A focus on non-benzodiazepine GABAergic medicationsLorenzo Leggio, George A Kenna, Robert M Swift
Psychopharmacology|February 21, 2018
Noradrenergic targets for the treatment of alcohol use disorderCarolina L Haass-Koffler, Robert M Swift, Lorenzo Leggio
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2004
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, part 1George A Kenna, John E McGeary, Robert M Swift
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 8, 2004
Pharmacotherapy, pharmacogenomics, and the future of alcohol dependence treatment, Part 2George A Kenna, John E McGeary, Robert M Swift
Current Pharmaceutical Design|April 29, 2011
Current and promising pharmacotherapies, and novel research target areas in the treatment of alcohol dependence: a reviewSteven Edwards, George A Kenna, Robert M Swift, et al.
Neuropsychology Review|July 10, 2012
The relationship of appetitive, reproductive and posterior pituitary hormones to alcoholism and craving in humansGeorge A Kenna, Robert M Swift, Thomas Hillemacher, et al.
Substance Use & Misuse|December 23, 2009
HIV testing in hazardous drinking: a survey analysisMiriam Fenton, Lorenzo Leggio, George A Kenna, et al.
Pageof 9